Journal
JOURNAL OF IMMUNOLOGY
Volume 177, Issue 5, Pages 2976-2984Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.177.5.2976
Keywords
-
Categories
Ask authors/readers for more resources
We previously showed that naive CD4(+) Th cells acquire peptide-MHC class I (pMHC 1) and costimulatory molecules from OVA-pulsed dendritic cells(DCOVA), and act as Th-APCs in stimulation of CD8(+)CTL responses. In this study, we further demonstrated that naive CD8(+) cytotoxic T (Tc) cells also acquire pMHC I and costimulatory CD54 and CD80 molecules by DCOVA stimulation, and act as Tc-APC. These Tc-APC can play both negative and positive modulations in antitumor immune responses by eliminating DCOVA and neighboring Tc-APC, and stimulating OVA-specific CD8(+) central memory T responses and antitumor immunity. Interestingly, the stimulatory effect of Tc-APC is mediated via its IL-2 secretion and acquired CD80 co-stimulation, and is specifically targeted to OVA-specific CD8(+) T cells in vivo via its acquired pMHC I complexes. These principles could be applied to not only antitumor immunity, but also other immune disorders (e.g., autoimmunity).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available